This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Maria Maier - Innovator in Glycoengineering
Introduction
Maria Maier is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of glycoengineering, particularly in the development of erythropoiesis stimulating proteins. Her innovative approach has led to advancements that could impact medical treatments and therapies.
Latest Patents
Maria Maier holds a patent for a method for in vitro glycoengineering of an erythropoiesis stimulating protein. This invention involves a detailed process that includes providing sialic acid-free erythropoiesis stimulating protein, treating it with N-Acetyl-Glucosamin-transferase B3GNT2, followed by treatment with galactosyltransferase, and finally with sialyltransferase. This method enhances the production of glycoengineered proteins, which are crucial for various therapeutic applications.
Career Highlights
Throughout her career, Maria has worked with notable companies in the pharmaceutical industry. She has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG, where she has contributed her expertise in biochemistry and protein engineering. Her work has been instrumental in advancing the understanding and application of glycoengineering techniques.
Collaborations
Maria has collaborated with various professionals in her field, including her coworker Marco Thomann. These collaborations have fostered innovation and have led to the successful development of her patented methods.
Conclusion
Maria Maier is a trailblazer in the field of glycoengineering, with her innovative methods paving the way for future advancements in medical treatments. Her contributions are a testament to the impact of dedicated inventors in the scientific community.